A new deployment testbed, READY, shows that near-identical benchmark accuracy can hide large differences in the human review needed to reach a reliability target; it picks the cheapest oversight policy that meets a given safety threshold and statistically qualifies that operating point on held-out cases.

Main Finding

READY (Reliable Enterprise Agent Deployment) is a deployment-centered evaluation framework that moves beyond autonomous capability metrics and measures whether an AI agent can meet a specified reliability target under explicit human-oversight policies and at an acceptable operating cost. By optimizing oversight policies and statistically qualifying the chosen policy on held-out cases, READY produces a deployment profile (reliability, human-review burden, cost, risk) that can differ substantially between agents with nearly identical autonomous accuracy.

Key Points

• Deployment objective: choose an oversight policy π from a candidate class Π that minimizes expected operating cost C(π) subject to meeting a workflow-specific reliability target R(π) ≥ Y (and optional risk constraints).
• Formal setup: workflows w → environment Ew, instance distribution Dw, evaluator gw producing multidimensional measurements q, success predicate ϕw producing binary outcome u. Reliability Rm,w(π)=E[u], cost Cm,w(π)=E[K].
• Three-phase flow: (1) workflow evaluation (record agent trajectories and measurements), (2) oversight-policy optimization (select lowest-cost feasible π on development data), (3) deployment qualification (freeze π* and statistically test on held-out cases).
• Policy types: accept/escalate/clarify/correct/takeover; distinction between trajectory-invariant policies (can replay saved runs) and trajectory-dependent policies (must re-run or simulate because interventions change trajectories).
• Open testbed: READY decouples workflow specification from deployment qualification and reuses existing agent-eval infra; workflows retain their own success definitions and evidence/observable signals.
• Key empirical finding (clinical-audit case study): among 16 agent systems evaluated on 750 retrospective clinical-audit cases, small differences in autonomous accuracy can mask large differences in deployment cost. Example: GPT-5.4 (72.8% autonomous accuracy) vs Sonnet 5 (72.5%) — to qualify at the same 76% reliability target under the evaluated policy, they required 39.2% vs 29.6% human review respectively. Reported operating cost example ≈ $5.50 per case and autonomous coverage ~78% for a qualified system in the worked example.
• READY complements capability benchmarks (it does not replace them): it answers “under what oversight conditions and cost can this agent actually be deployed?” rather than just “how often is the agent correct autonomously?”

Data & Methods

• Formal definitions:
  • Workflow w with execution environment Ew and instance distribution Dw. Evaluation set Sw = {xi} sampled iid from Dw.
  • Agent m run under policy π produces trajectory Zπ_i = Execute(m, xi, Ew; π).
  • Evaluator gw maps Zπ_i → measurement vector qπ_i; success predicate ϕw: q → u ∈ {0,1}.
  • Reliability Rm,w(π) = E[u]; expected cost Cm,w(π) = E[K(Zπ)].
  • Feasible policy set Fm,w(Y,Bw) = {π ∈ Πw : Rm,w(π) ≥ Y, risk ≤ Bw}; select π* ∈ argmin_{π∈Fm} C(π).
• Statistical protocol:
  • Policy selection is performed on development data.
  • The selected policy π* is frozen and evaluated on held-out qualification data to statistically support (or reject) the requested reliability target and risk bounds.
  • This guards against overfitting oversight rules to the development sample.
• Implementation & case study:
  • Open testbed built on existing agent-evaluation infrastructure; seed workflow is retrospective clinical audit (CliniCARE-Bench).
  • Environment examples include MIMIC-IV chart data; tasks ask agents to adjudicate clinical events (e.g., AKI after CT) with evidence citations and confidence scores.
  • Empirical instantiation evaluated 16 agent systems on 750 cases; oversight policies used signals such as agent confidence and evidence citations; costs modeled as agent compute + human reviewer time (monetized).
  • Policy evaluation modes considered replayable (terminal accept/escalate) and trajectory-dependent interventions (corrections, takeovers).
• Limitations, assumptions noted by authors:
  • Results depend on the chosen policy class Π, representativeness of Sw and Ew, human-review models, and cost assumptions.
  • Trajectory-dependent policies require more complex simulation or re-execution to estimate R and C accurately.

Implications for AI Economics

• Procurement and vendor comparison: READY provides economically meaningful comparators—rank models by the cost of achieving required reliability (including human oversight) rather than raw accuracy, enabling better procurement decisions and supplier selection.
• Cost–benefit and ROI analysis: firms can quantify trade-offs between additional model capability and reduced human review burden, enabling explicit return-on-investment calculations for model upgrades or human staffing.
• Pricing and business models: deployment profiles support pricing of AI-assisted services that incorporate oversight costs, SLA design (guaranteed reliability levels), and tiered offerings based on supported operating points.
• Labor allocation and workflow design: READY quantifies how much human review is needed for a target reliability, helping organizations plan workforce capacity, shift tasks between automation and human specialists, and assess labor cost savings.
• Risk management, regulation, and insurance: explicit, statistically qualified reliability and risk metrics enable better compliance evidence, regulatory submissions, and actuarial assessment for liability/insurance pricing tied to human–AI system reliability.
• Market differentiation & contracting: firms can market models not only on benchmark accuracy but on favorable reliability–cost frontiers; contracts can be structured around certified deployment profiles.
• Incentives for model development: developers may optimize models for improved calibration, explainability, or signals that reduce necessary oversight (e.g., better confidence estimates, higher-quality evidence citations) rather than only point accuracy—because those properties materially affect operating cost.
• Research and policy direction: READY frames deployment as constrained optimization, motivating research on selective prediction, abstention, routing/cascades, and cost-aware human-in-the-loop strategies with direct economic relevance.

Overall, READY operationalizes the economic question firms face when deciding whether and how to deploy agents: not just “can the agent do the task?” but “under what oversight policy, at what reliability, and at what cost can it be deployed?”